Both aspirin and warfarin are effective methods of secondary prevention after myocardial infarction, but their role in primary prevention of ischemic heart disease (IHD) remains unsettled. In this trial from the U.K., 5,085 men aged 45 to 69 and at high risk for IHD were randomized to low-dose aspirin (75 mg daily), low-dose warfarin …